Journal
Information Content Entity
Continuant
Entity
Periodical
Generically Dependent Continuant
Collection
Decline of CD4¿ T-cell count before start of therapy and immunological response to treatment in antiretroviral-naive individuals.
The effect of antiretroviral treatment of different durations in primary HIV infection.
Abacavir-based therapy does not affect biological mechanisms associated with cardiovascular dysfunction
Risk Factors foe sexual and erectil dysfunction in HIV-infected men: the role of protease inhibitors
CASCADE Collaboration. Short term risk of AIDS by current CD4, viral load and age in naïve individuals and those treated in the monotherapy era.
Differences in the causes of death of HIV-positive subjects in a cohort study by data sources and coding algorithms
Rilpivirine resistance mutations in HIV patients failing non-nucleoside reverse transcriptase inhibitor-based therapies.
High-grade anal intraepithelial neoplasia is associated with HIV-1 RNA rectal shedding in virologically suppressed MSM.
HIV health experiences among migrant Africans ¿ How are we doing?
Chronotropic incompetence in HIV infection
Incidence and clearance of anal high-risk human papillomavirus in HIV-positive men who have sex with men: estimates and risk factors
Relationship between ankle-brachial index and carotid intima-media thickness in HIV-infected patients.
Risk factors foe sexual and erectile dysfunction in HIV-infected men: the role of protease inhibitors
Hospital admissions in individuals with HTLV-1 infection in Spain
Effective therapy has altered the spectrum of causespecific mortality following HIV seroconversion
Short-term risk of AIDS according to current CD4 cell count and viral load in antiretroviral drug-naive individuals and those treated in the monotherapy era
Relationship between ankle-brachial index and carotid intima-media thickness in HIV-infected-patients
Survival and progression to AIDS in a seroconverter cohort in the post-highly active antiretroviral therapy era: effectiveness goes on.
Lopinavir-ritonavir monotherapy versus lopinavir-ritonavir and two nucleosides for maintenance therapy of HIV.
Etravirine RAMs in HIV Patients Failing Efavirenz or Nevirapine in the Spanish Antiretroviral Resistance Database
Substitution of raltegravir for ritonavir-boosted protease inhibitors in HIV-infected patients: the SPIRAL study
Changes in cardiovascular biomarkers in HIV-infected patients switching from ritonavir-boosted protease inhibitors to raltegravir
Fixed-dose darunavir/cobicistat in pregnancy of HIV-infected women, pharmacokinetic concerns
Association between IL28B gene polymorphisms and plasma HCV-RNA levels in HIV/HCV-co-infected patients.
Geography of medical publications. An overview of HIV/AIDS research in 2003.
Monitoring HIV/AIDS in migrants communities in Europe.
Induction therapy with trizivir plus efavirenz or lopinavir/ritonavir followed by trizivir alone in naive HIV-1-infected adults.
Using phylogenetic analysis to trace HIV-1 migration among western European injecting drug users seroconverting from 1984 to 1997.
Interferon-free therapy for treating hepatitis C virus in difficult-to-treat HIV-coinfected patients
Trends in hospitalizations and deaths in HIV-infected patients in Spain over two decades AIDS. 2022
Techniques for measuring regional body fat: computed tomography may be suitable for evaluation of facial lipoatrophy
Touloumi G, Pantazis N, Babiker AG, Walker SA, Katsarou O, Karafoulidou A, Hatzakis A, Porter K; CASCADE Collaboration. Differences in HIV RNA levels before the initiation of antiretroviral therapy among 1864 individuals with known HIV-1 seroconversion dates.
Impact of hepatitis C infection on long-term mortality of infection drug users from 1990 to 2002 differences before and after HAART
Trends in hospitalizations and deaths in HIV-Infected patients in Spain over two decades
CASCADE Collaboration. Systemic non-Hodgkin lymphoma in persons with known dates of HIV seroconversion: incidence and predictors.
Tuberculosis risk varies with the duration of HIV infection: a prospective study of European drug users with known date of HIV seroconversion
The effect of efavirenz versus nevirapine-containing regimens on immunologic, virologic and clinical outcomes in a prospective observational study
Slower CD4 cell decline following cessation of a 3 month course of HAART in primary HIV infection: findings from an observational cohort
The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals
Changes in the incidence of tuberculosis in a cohortof HIV-seroconverters before and after the introduction of HAART
Spontaneous control of viral load and CD4 cell count progression among HIV-1 seroconverters.
Systemic non-Hodgkin lymphoma in individuals with known dates of HIV seroconversion: incidence and predictors
Differences in HIV RNA levels before the initiation of antiretroviral therapy among 1864 individuals with known HIV-1 seroconversion dates
Unexpected improvement of sexual dysfunction during atazanavir therapy.
Risk, predictors, and mortality associated with non-AIDS events in newly diagnosed HIV-infected patients: role of antiretroviral therapy
Switching from a ritonavir-boosted protease inhibitor to a dolutegravir based regimen for maintenance of HIV viral suppression in patients with high cardiovascular risk
Incidence and clearance of anal high-risk human papillomavirus in HIV-positive men who have sex with men: estimates and risk factors.
Hepatitis delta in patients hospitalized in Spain (1997-2018)
X4 tropic viruses are on the rise in recent HIV-1 seroconverters in Spain.
Effectiveness of highly active antiretroviral therapy in Spanish cohorts of HIV seroconverters: differences by transmission category
Effectiveness of highly active antiretroviral therapy in Spanish cohorts of HIV seroconverters: ifferences by transmission category
Lopinavir plasma concentrations and changes in lipid levels during salvage therapy with lopinavir/ritonavir-containing regimens
Avascular necrosis of the bone in HIV-infected patients: Incidence and associated factors
RDF description of AIDS - http://research.umh.es/vivo/pub/revista/0269-9370